Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System

Valeria Panebianco; Alberto Briganti; Thierry N. Boellaard; James Catto; Eva Comperat; Jason Efstathiou; Antoine G. van der Heijden; Gianluca Giannarini; Rossano Girometti; Laura Mertens; Mitsuru Takeuchi; Valdair F. Muglia; Yoshifumi Narumi; Giacomo Novara; Martina Pecoraro; Morgan Roupret; Francesco Sanguedolce; Daniele Santini; Shahrokh F. Shariat; Giuseppe Simone; Hebert A. Vargas; Sungmin Woo; Jelle Barentsz; J. Alfred Witjes

doi:10.1038/s41585-023-00830-2

Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System

Valeria Panebianco, Alberto Briganti, Thierry N. Boellaard, James Catto, Eva Comperat, Jason Efstathiou, Antoine G. van der Heijden, Gianluca Giannarini, Rossano Girometti, Laura Mertens, Mitsuru Takeuchi, Valdair F. Muglia, Yoshifumi Narumi, Giacomo Novara, Martina Pecoraro, Morgan Roupret, Francesco Sanguedolce, Daniele Santini, Shahrokh F. Shariat, Giuseppe SimoneHebert A. Vargas, Sungmin Woo, Jelle Barentsz, J. Alfred Witjes

Urology (VUmc)

Research output: Contribution to journal › Article › Academic › peer-review

2 Citations (Scopus)

Abstract

Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.

Original language	English
Pages (from-to)	243-251
Number of pages	9
Journal	Nature Reviews Urology
Volume	21
Issue number	4
DOIs	https://doi.org/10.1038/s41585-023-00830-2
Publication status	Published - 1 Apr 2024

Access to Document

10.1038/s41585-023-00830-2

Cite this

Panebianco, V., Briganti, A., Boellaard, T. N., Catto, J., Comperat, E., Efstathiou, J., van der Heijden, A. G., Giannarini, G., Girometti, R., Mertens, L., Takeuchi, M., Muglia, V. F., Narumi, Y., Novara, G., Pecoraro, M., Roupret, M., Sanguedolce, F., Santini, D., Shariat, S. F., ... Witjes, J. A. (2024). Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System. Nature Reviews Urology, 21(4), 243-251. https://doi.org/10.1038/s41585-023-00830-2

@article{970968021e9a46d78dcc95ffa9cc5b2b,

title = "Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System",

abstract = "Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.",

author = "Valeria Panebianco and Alberto Briganti and Boellaard, {Thierry N.} and James Catto and Eva Comperat and Jason Efstathiou and {van der Heijden}, {Antoine G.} and Gianluca Giannarini and Rossano Girometti and Laura Mertens and Mitsuru Takeuchi and Muglia, {Valdair F.} and Yoshifumi Narumi and Giacomo Novara and Martina Pecoraro and Morgan Roupret and Francesco Sanguedolce and Daniele Santini and Shariat, {Shahrokh F.} and Giuseppe Simone and Vargas, {Hebert A.} and Sungmin Woo and Jelle Barentsz and Witjes, {J. Alfred}",

note = "Publisher Copyright: {\textcopyright} Springer Nature Limited 2023.",

year = "2024",

month = apr,

day = "1",

doi = "10.1038/s41585-023-00830-2",

language = "English",

volume = "21",

pages = "243--251",

journal = "Nature Reviews Urology",

issn = "1759-4812",

publisher = "Nature Publishing Group",

number = "4",

}

Panebianco, V, Briganti, A, Boellaard, TN, Catto, J, Comperat, E, Efstathiou, J, van der Heijden, AG, Giannarini, G, Girometti, R, Mertens, L, Takeuchi, M, Muglia, VF, Narumi, Y, Novara, G, Pecoraro, M, Roupret, M, Sanguedolce, F, Santini, D, Shariat, SF, Simone, G, Vargas, HA, Woo, S, Barentsz, J & Witjes, JA 2024, 'Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System', Nature Reviews Urology, vol. 21, no. 4, pp. 243-251. https://doi.org/10.1038/s41585-023-00830-2

TY - JOUR

T1 - Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System

AU - Panebianco, Valeria

AU - Briganti, Alberto

AU - Boellaard, Thierry N.

AU - Catto, James

AU - Comperat, Eva

AU - Efstathiou, Jason

AU - van der Heijden, Antoine G.

AU - Giannarini, Gianluca

AU - Girometti, Rossano

AU - Mertens, Laura

AU - Takeuchi, Mitsuru

AU - Muglia, Valdair F.

AU - Narumi, Yoshifumi

AU - Novara, Giacomo

AU - Pecoraro, Martina

AU - Roupret, Morgan

AU - Sanguedolce, Francesco

AU - Santini, Daniele

AU - Shariat, Shahrokh F.

AU - Simone, Giuseppe

AU - Vargas, Hebert A.

AU - Woo, Sungmin

AU - Barentsz, Jelle

AU - Witjes, J. Alfred

PY - 2024/4/1

Y1 - 2024/4/1

N2 - Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.

AB - Diagnostic work-up and risk stratification in patients with bladder cancer before and after treatment must be refined to optimize management and improve outcomes. MRI has been suggested as a non-invasive technique for bladder cancer staging and assessment of response to systemic therapy. The Vesical Imaging-Reporting And Data System (VI-RADS) was developed to standardize bladder MRI image acquisition, interpretation and reporting and enables accurate prediction of muscle-wall invasion of bladder cancer. MRI is available in many centres but is not yet recommended as a first-line test for bladder cancer owing to a lack of high-quality evidence. Consensus-based evidence on the use of MRI-VI-RADS for bladder cancer care is needed to serve as a benchmark for formulating guidelines and research agendas until further evidence from randomized trials becomes available.

UR - http://www.scopus.com/inward/record.url?scp=85178190938&partnerID=8YFLogxK

U2 - 10.1038/s41585-023-00830-2

DO - 10.1038/s41585-023-00830-2

M3 - Article

C2 - 38036666

SN - 1759-4812

VL - 21

SP - 243

EP - 251

JO - Nature Reviews Urology

JF - Nature Reviews Urology

IS - 4

ER -

Clinical application of bladder MRI and the Vesical Imaging-Reporting And Data System

Abstract

Access to Document

Other files and links

Cite this